Researcher
August Verbruggen
- Disciplines:Endocrinology and metabolic diseases, Paediatrics and neonatology, Nursing
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From22 Oct 2018 → 21 Oct 2020 - Department of Internal medicine (Department)
Member
From1 Oct 1993 → 30 Sep 2018
Publications
1 - 10 of 69
- Etanercept in patients with inflammatory hand osteoarthritis (EHOA) : a multicentre, randomised, double-blind, placebo-controlled trial(2018)
Authors: Margreet Kloppenburg, Roberta Ramonda, Klaus Bobacz, Wing-Yee Kwok, Tom WJ Huizinga, Feline PB Kroon, Leonardo Punzi, Josef S Smolen, Bert Vander Cruyssen, Ron Wolterbeek, et al.
Pages: 1757 - 1764 - Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study(2018)
Authors: Bieke Lambert, Paulien Meersseman, August Verbruggen, Filip Van den Bosch
Pages: 310 - 311 - 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients : a biodistribution and dosimetry study(2016)
Authors: Bieke Lambert, Filip Van den Bosch, August Verbruggen, Rudi Beyaert, Caroline Dumolyn, Filip De Vos
- Baseline scintigraphic detection of TNFa as a predictor of therapy response after treatment with certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients(2014)Volume: 66
Authors: Bieke Lambert, Filip De Vos, August Verbruggen, Filip Van den Bosch
Pages: S933 - S933 - 99mTc labelled S-HYNIC certolizumab pegol for selecting patients for anti-TNF alpha treatment: a biodistribution and dosimetric study(2013)Volume: 40
Authors: Bieke Lambert, Philippe Carron, Yves D'Asseler, Klaus Bacher, Filip Van den Bosch, Lennart Jans, Dirk Elewaut, August Verbruggen, Filip De Vos
Pages: S392 - S392 - Scintigraphic detection of TNF alpha with a radiolabeled anti-TNF alpha in patients with active peripheral spondyloarthritis and rheumatoid arthritis(2013)Volume: 65
Authors: Philippe Carron, Bieke Lambert, Filip De Vos, August Verbruggen, Dirk Elewaut, Filip Van den Bosch
Pages: S472 - S472 - Selecting patients with spondyloarthritis (SpA) or rheumatoid arthritis (RA) for antiTNF-alfa treatment: first scintigraphic data with Tc99m-labelled certolizumab pegol(2013)
Authors: Bieke Lambert, Filip Van den Bosch, August Verbruggen, Filip De Vos
Number of pages: 1 - Second generation characterized chondrocyte implantation for the treatment of cartilage lesions in the knee(2012)Volume: 20
Authors: Aad Dhollander, Peter Verdonk, Stijn Lambrecht, René Verdonk, Dirk Elewaut, August Verbruggen, Karl Almqvist
Pages: S39 - S39 - CD34 and SMA expression of superficial zone cells in the normal and pathological human meniscus(2012)
Authors: Heidi Declercq, Ramses Forsyth, August Verbruggen, René Verdonk, Maria Cornelissen, Peter Verdonk
Pages: 800 - 808 - Impairment and impact of pain in female patients with Ehlers-Danlos syndrome: a comparative study with fibromyalgia and rheumatoid arthritis(2011)
Authors: Lies Rombaut, Fransiska Malfait, STEVEN RIMBAUT, August Verbruggen, Inge De Wandele
Pages: 1979 - 1987